Abstract: A method is provided for identifying a restriction endonuclease, which includes the steps of (a) screening a target DNA sequence for the presence of known methylase sequence motifs, (b) identifying any open reading frames which lie close to the methylase sequence motifs screened in step (a), and (c) assaying the protein products of these open reading frames for restriction endonuclease activity. Methods for identifying isoschizomers of known restriction endonucleases, which isoschizomers possess a desired physical property, such as thermostability, are also provided by the present invention, as are several novel restriction endonucleases isolated from M. jannaschii, MjaIII and MjaIV. Additionally, a gene was identified that encoded a previously observed endonuclease activity, designated MjaII. Also provided by the present invention are vectors suitable for cloning a DNA sequence encoding a cytotoxic protein, via independent transcription promotors which may be selectively controlled by several conditions.
Type:
Grant
Filed:
February 25, 2000
Date of Patent:
May 7, 2002
Assignee:
New England Biolabs, Inc.
Inventors:
Richard J. Roberts, Devon R. Byrd, Richard D. Morgan, Jay Patti, Christopher J. Noren
Abstract: Substantially pure glycosidases capable for cleaving selected glycosidic bonds have been described including glycosidases isolated from Xanthomonas and recombinant glycosidases. Substrate specificity of isolated enzymes have been identified for GlcNac&bgr;1-X, Gal&agr;1-3R, Gal&agr;1-6R, Gal&bgr;1-3R, Fuc&agr;-2R, Fuc&agr;1-3R, Fuc&agr;1-4R, Man&agr;1-2R, Man&agr;1-3R, Man&agr;1-6R, Man&bgr;1-4R, Xyl&bgr;1-2R, Glc&bgr;1-4R, and Gal&bgr;1-4R providing improved capability for selectively cleaving a glycosidic linkage in a carbohydrate substrate and for forming modified carbohydrates.
Type:
Grant
Filed:
June 18, 2001
Date of Patent:
March 19, 2002
Assignee:
New England Biolabs, Inc.
Inventors:
Sharon T. Wong-Madden, Ellen P. Guthrie, David Landry, Christopher H. Taron, Chudi Guan, Phillips W. Robbins
Abstract: Substantially pure glycosidases capable for cleaving selected glycosidic bonds have been described including glycosidases isolated from Xanthomonas and recombinant glycosidases. Substrate specificity of isolated enzymes have been identified for GlcNac&bgr;1-X, Gal&agr;1-3R, Gal&agr;1-6R, Gal&bgr;1-3R, Fuc&agr;1-2R, Fuc&agr;1-3R, Fuc&agr;1-4R, Man&agr;1-2R, Man&agr;1-3R, Man&agr;1-6R, Man&bgr;1-4R, Xyl&bgr;1-2R, Glc&bgr;1-4R, and Gal&bgr;1-4R providing improved capability for selectively cleaving a glycosidic linkage in a carbohydrate substrate and for forming modified carbohydrates.
Type:
Grant
Filed:
February 24, 1999
Date of Patent:
January 29, 2002
Assignee:
New England Biolabs, Inc.
Inventors:
Sharon T. Wong-Madden, Ellen P. Guthrie, David Landry, Christopher H. Taron, Chudi Guan, Phillips W. Robbins
Abstract: The present invention relates to recombinant DNA which encodes the BsmI restriction endonuclease as well as BsmI methyltransferases, expression of BsmI restriction endonuclease in E. coil cells containing the recombinant DNA by using a low copy number T7 expression vector pACYC-T7ter, and purification of BsmI restriction endonuclease by heat treatment and chromatography through heparin Sepharose column.
Abstract: Substantially pure glycosidases capable for cleaving selected glycosidic bonds have been described including glycosidases isolated from Xanthomonas and recombinant glycosidases. Substrate specificity of isolated enzymes have been identified for GlcNac&bgr;1-X, Gal&agr;1-3R, Gal&agr;1-6R, Gal&bgr;1-3R, Fuc&agr;-2R, Fuc&agr;1-3R, Fuc&agr;1-4R, Man&agr;1-2R, Man&agr;1-3R, Man&agr;1-6R, Man&bgr;1-4R, Xyl&bgr;1-2R, Glc&bgr;1-4R, and Gal&bgr;1-4R providing improved capability for selectively cleaving a glycosidic linkage in a carbohydrate substrate and for forming modified carbohydrates.
Abstract: In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori J99 (NEB#1237), hereinafter referred to as “Hpy99I”, which endonuclease:
(1) recognizes the nucleotide sequence 5′-CGWCG-3′ in a double-stranded DNA
(wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and W represents either A, or T);
(2) cleaves double-stranded PhiX174 DNA to produce 8 fragments, including fragments of 3063, 629, 602, 447, 389, and 176 base pairs, and 2 fragments smaller than 100 base pairs.
Type:
Grant
Filed:
September 23, 1999
Date of Patent:
August 28, 2001
Assignees:
New England Biolabs, Inc., Vanderbilt University
Abstract: In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori J188 (NEB#1174), hereinafter referred to as “Hpy188I”, which endonuclease:
(1) recognizes the nucleotide sequence 5′-TCNGA-3′ in a double-stranded DNA molecule as shown below,
5′-TCN↓GA-3′
3′-AG↑NCT-5′
(wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T);
(2) cleaves said sequence in the phosphodiester bonds between the N and G as indicated with the arrows; and
(3) cleaves double-stranded PhiX174 DNA to produce 18 fragments, including fragments of 1331, 813, 572, 525, 396, 302, 293, 219 base pairs, and 10 fragments smaller than 200 base pairs.
Type:
Grant
Filed:
September 10, 1999
Date of Patent:
July 10, 2001
Assignees:
New England Biolabs, Inc., Vanderbilt University
Abstract: The present invention relates to the recombinant DNA which encodes the SwaI restriction endonuclease, modification methylase, and the production of SwaI restriction endonuclease from the recombinant DNA. Related expression vectors, pHKUV5 which features a strong, constitutive UV5 promoter without the Lac repressor binding site and pHKT7 which contains a powerful controllable T7 promoter and a low copy number origin of replication, are also disclosed.
Type:
Grant
Filed:
April 27, 1999
Date of Patent:
June 12, 2001
Assignee:
New England Biolabs, Inc.
Inventors:
Huimin Kong, Lauren S. Higgins, Michael A. Dalton
Abstract: In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori J188 (NEB#1174), hereinafter referred to as “Hpy188III”, which endonuclease:
(1) recognizes the nucleotide sequence 5′-TCNNGA-3′ in a double-stranded DNA molecule as shown below,
5′-TC↓NNGA-3′
3′-AGNN↑CT-5′
(wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T);
(2) cleaves said sequence in the phosphodiester bonds between the C and first unspecified nucleotide N as indicated with the arrows; and
(3) cleaves double-stranded PhiX174 DNA to produce 26 fragments, including fragments of 704, 560, 497, 477, 423, 309, 308, 304, 261, 225 basepairs, and 16 fragments smaller than 200 basepairs.
Type:
Grant
Filed:
September 23, 1999
Date of Patent:
May 29, 2001
Assignees:
New England Biolabs, Inc., Vanderbilt University
Abstract: In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori CH4 (NEB#1236), hereinafter referred to as “HpyCH4III”, which endonuclease:
(1) recognizes the nucleotide sequence 5′-ACNGT-3′ in a double-stranded DNA molecule as shown below,
5′-ACN↓GT-3′
3′-TG↑NCA-5′
(wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T);
(2) cleaves said sequence in the phosphodiester bonds between the N and G as indicated with the arrows; and
(3) cleaves double-stranded PhiX174 DNA to produce 15 fragments, including fragments of 1284, 814, 536, 517, 454, 404, 302, 292, 270 and 222 base pairs, and 5 fragments smaller than 200 base pairs.
Type:
Grant
Filed:
September 23, 1999
Date of Patent:
May 29, 2001
Assignees:
New England Biolabs, Inc., Vanderbilt University
Abstract: RsaI, a restriction enzyme from the bacterium Rhodopseudomonas sphaeroides, recognizes the DNA sequence 5′-GTAC-3′. Because RsaI is commercially valuable, we sought to overproduce it by cloning the genes for RsaI and its accompanying, modification, enzyme. The ‘methylase-selection’ method, the customary procedure for cloning restriction and modification genes, was applied to RsaI. The method yielded clones containing the methylase gene (rsaIM), but none containing both the methylase gene and the restriction gene (rsaIR). Inverse-PCR was then used to recover sections of the DNA downstream of rsaIM. These sections were sequenced, and the sequences were joined in silico to reveal the gene organization of the RsaI R-M system.
Type:
Grant
Filed:
June 2, 2000
Date of Patent:
April 3, 2001
Assignee:
New England Biolabs, Inc.
Inventors:
Keith D. Lunnen, Richard D. Morgan, Timothy Meixsell, Geoffrey G. Wilson
Abstract: In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori CH4 (NEB#1236), hereinafter referred to as “HpyCH4IV”, which endonuclease:
(1) recognizes the nucleotide sequence 5′-ACGT-3′ to in a double-stranded DNA molecule as shown below,
5′-A↓CGT-3′
3′-TGC↑A-5′
(wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T);
(2) cleaves said sequence in the phosphodiester bonds between the A and C as indicated with the arrows; and
(3) cleaves double-stranded PhiX174 DNA to produce 19 fragments, including fragments of 1036, 749, 397, 379, 371, 365, 362, 343, 282, 282, 268 base pairs, and 8 fragments smaller than 200 base pairs.
Type:
Grant
Filed:
September 23, 1999
Date of Patent:
February 27, 2001
Assignees:
New England Biolabs, Inc., Vanderbilt University
Abstract: The present invention relates to recombinant DNA which encodes a novel nicking endonuclease, N.BstNBI, and the production of N.BstNBI restriction endonuclease from the recombinant DNA utilizing PleI modification methylase. Related expression vectors, as well as the application of N.BstNBI in non-thio strand displacement amplification, is disclosed also.
Type:
Grant
Filed:
June 2, 2000
Date of Patent:
February 20, 2001
Assignee:
New England Biolabs, Inc.
Inventors:
Huimin Kong, Lauren S. Higgins, Michael Dalton, Rebecca B. Kucera, Ira Schildkraut
Abstract: The present invention relates to the use of these cyclophilins, hereinafter referred to as `tyrosine-containing` cyclophilins, in a method for identifying compounds capable of binding to and/or inhibiting the enzymatic activity of these proteins. Such compounds may be further screened for their ability to inhibit parasites which are not susceptible to the anti-parasitic effects of CsA.
Type:
Grant
Filed:
February 24, 1998
Date of Patent:
November 21, 2000
Assignee:
New England Biolabs, Inc.
Inventors:
Clotilde K. S. Carlow, Xiqiang Hong, Dong Ma
Abstract: A genomic DNA library of Thermus filiformis was constructed using pBR322 as a cloning vector. The methylase selection method was used to clone the TfiI methylase gene (tfiIM). A clone carrying an active TfiI methylase was identified. After sequencing the complete TfiI methylase gene and its downstream DNA sequence, a recombinase homolog was found. Because the methylase and its cognate endonuclease gene are located in proximity to each other in a particular restriction-modification system, efforts were made to clone the upstream DNA by inverse PCR. After two rounds of inverse PCR, one open reading frame (ORF1) was found upstream of the TfiI methylase gene. This ORF1, containing a Shine-Dalgarno sequence and a TATA box on the upstream side, was cloned and expressed, and TfiI endonuclease activity was detected in crude cell extracts. It is concluded that ORF1 encodes TfiI restriction endonuclease.
Abstract: The present invention relates to recombinant DNA molecules encoding NspHI restriction endonuclease and methylase and to method to use premodified E. coli K strain RR1 (.lambda.DE3) for overexpression of NspHI restriction endonuclease.
Abstract: The present invention relates to the use of nematode "cyclophilin-like proteins (CLP)", in a method for identifying compounds capable of binding to and/or inhibiting the peptidyl-prolylcistransisomerase activity of these proteins. Such compounds may be further screened for their ability to inhibit nematode parasites which are not susceptible to the anti-parasitic effects of CsA.
Abstract: In accordance with the present invention, a 31-33 kDa glycoprotein of D. immitis (DiT33) is provided which represents another member of the family of putative pepsin inhibitors. Other known members include Ov33 (a.k.a. Ov33.3, Oc3.6, OvD 5B), Bm33 and Av33. These filarial molecules possess significant homology to the known pepsin inhibitor (Aspi3) of A. suum. Using DiT33 or Ov33, in the form of a recombinant fusion or non-fusion protein, antibody responses to DiT33 may be monitored and used in immunodiagnosis of heartworm infection in mammals. Antibodies reactive with the DiT33 or Ov33 may also be used to detect DiT33 antigen as a means of immunodiagnosis of heartworm infection in mammals.
Type:
Grant
Filed:
April 29, 1997
Date of Patent:
August 15, 2000
Assignee:
New England Biolabs, Inc.
Inventors:
Clotilde K. S. Carlow, Francine B. Perler, XiaQiang Hong, Jhon Santiago Mejia
Abstract: BsrFI restriction enzyme was purified from Bacillus stearothermophilus to near homogeneity. The protein was sequenced to obtain its N-terminus amino acid sequence. A set of denegerate primers were synthesized based on the aa sequence. The first 18 codons encoding BsrFI restriction endonuclease (bsrFIR) was amplified by PCR and its coding sequence was obtained. The methylase selection method was used to clone BsrFI methylase gene (bsrFIM). Two clones were found to be resistant to BsrFI digstion. The entire insert in one clone was sequenced and the insert encodes the BsrFI methylase (M. BsrFI). In addition, a small truncated open reading frame adjacent to the methylase gene has homology to Cfr10I restriciton endonuclease in a BlastX homology search in Genbank database. BsrFI and Cfr10I are isoschizomer that recognizes and cleaves 5'R CCGGY3'.